Literature DB >> 25754453

Effectiveness of mechanical chest compression for out-of-hospital cardiac arrest patients in an emergency department.

Ching-Kuo Lin1, Mei-Chin Huang2, Yu-Tung Feng3, Wei-Hsuan Jeng1, Te-Cheng Chung1, Yu-Wa Lau1, Kuang-I Cheng4.   

Abstract

BACKGROUND: To increase the chance of restoring spontaneous circulation, cardiopulmonary resuscitation (CPR) with high-quality chest compressions is needed. We hypothesized that, in a municipal hospital emergency department, the outcome in nontraumatic out-of-hospital cardiac arrest patients treated with standard CPR followed by mechanical chest compression (MeCC) was not inferior to that followed by manual chest compression (MaCC). The purposes of the study were to test our hypothesis and investigate whether the use of MeCC decreased human power demands for CPR.
METHODS: A total of 455 consecutive out-of-hospital cardiac arrest patients of presumed cardiac etiology were divided into two groups according to the chest compressions they received (MaCC or MeCC) in this retrospective review study. Human power demand for CPR was described according to the Basic Life Support/Advanced Cardiovascular Life Support guidelines and the device handbook. The primary endpoint was recovery of spontaneous circulation during resuscitation, and the secondary endpoints were survival to hospital admission and medical human power demands.
RESULTS: In this study, recovery of spontaneous circulation was achieved in 33.3% of patients in the MeCC group and in 27.1% in the MaCC group (p = 0.154), and the percentages of patients who survived hospitalization were 22.2% and 17.6%, respectively (p = 0.229). A ratio of 2:4 for the human power demand for CPR between the groups was found. Independent predictors of survival to hospitalization were ventricular fibrillation/pulseless ventricular tachycardia as initial rhythm and recovery of spontaneous circulation.
CONCLUSION: No difference was found in early survival between standard CPR performed with MeCC and that performed with MaCC. However, the use of the MeCC device appears to promote staff availability without waiving patient care in the human power-demanding emergency departments of Taiwan hospitals.
Copyright © 2015. Published by Elsevier Taiwan.

Entities:  

Keywords:  cardiac arrest; cardiopulmonary resuscitation; emergency department crowding; mechanical chest compression

Mesh:

Year:  2015        PMID: 25754453     DOI: 10.1016/j.jcma.2015.01.005

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  4 in total

1.  Manual cardiopulmonary resuscitation versus mechanical cardiopulmonary resuscitation: Which one is more effective during ambulance transport?

Authors:  İshak Şan; Burak Bekgöz; Mehmet Ergin; Eren Usul
Journal:  Turk J Emerg Med       Date:  2021-02-12

Review 2.  Comparison between Prehospital Mechanical Cardiopulmonary Resuscitation (CPR) Devices and Manual CPR for Out-of-Hospital Cardiac Arrest: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.

Authors:  Cheng-Ying Chiang; Ket-Cheong Lim; Pei Chun Lai; Tou-Yuan Tsai; Yen Ta Huang; Ming-Jen Tsai
Journal:  J Clin Med       Date:  2022-03-07       Impact factor: 4.241

3.  The Effect of Implementing Mechanical Cardiopulmonary Resuscitation Devices on Out-of-Hospital Cardiac Arrest Patients in an Urban City of Taiwan.

Authors:  Yi-Rong Chen; Chi-Jiang Liao; Han-Chun Huang; Cheng-Han Tsai; Yao-Sing Su; Chung-Hsien Liu; Chi-Feng Hsu; Ming-Jen Tsai
Journal:  Int J Environ Res Public Health       Date:  2021-03-31       Impact factor: 3.390

4.  Prognostic Impact of In-Hospital Use of Mechanical Cardiopulmonary Resuscitation Devices Compared with Manual Cardiopulmonary Resuscitation: A Nationwide Population-Based Observational Study in South Korea.

Authors:  Wonhee Kim; Chiwon Ahn; In-Young Kim; Hyun-Young Choi; Jae-Guk Kim; Jihoon Kim; Hyungoo Shin; Shinje Moon; Juncheol Lee; Jongshill Lee; Youngsuk Cho; Yoonje Lee; Dong-Geum Shin
Journal:  Medicina (Kaunas)       Date:  2022-02-27       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.